State Street or iShares: Which Consumer Staples ETF Offers Better Value?

The article compares two consumer-staples ETFs—State Street XLP ($13.7B AUM) with a 0.08% expense ratio versus iShares IYK ($1.3B AUM) at 0.38%—noting both have similar 5-year total returns (growth of $1,000: $1,359 vs $1,338) and identical trailing yields of 2.60%. XLP is positioned as a lower-fee, more concentrated “pure-play” (99% consumer defensive) with a slightly lower 1-year return (5.5% vs 5.9%) and similar risk (5-year max drawdown -16.3% vs -15.0%). Overall, the piece argues the lower 30bp+ annual fee drag in XLP can benefit long-term compounding, though investors’ choice should depend on desired breadth and existing portfolio exposures.

Analysis

This is more of a flow-and-vehicle story than a fundamental equity signal. If allocators lean into the lower-cost, more liquid defensive wrapper, the marginal buyer ends up concentrated in the same handful of megacaps, which mechanically supports WMT and COST first, then PG. That is a quiet reinforcement of existing quality-premium leadership rather than a new catalyst.

The second-order loser is the “broader defensive” basket: once healthcare and materials are mixed in, the product stops being a pure recession hedge and starts behaving like a hybrid factor bet. In a sharp risk-off tape, that can create tracking error versus a cleaner staples proxy; in a soft-landing rally, it can actually help, so relative performance should be judged against the macro regime, not just fee drag.

Contrarian view: the market may be overestimating how much a few basis points of expense ratio matter over the next quarter and underestimating valuation risk in the large-cap defensives. If rates fall and breadth improves, staples can still hold up but the multiple premium in WMT/COST/PG can compress. Falsifiers are a sustained rise in recession odds or a bond-yield spike; either would re-ignite demand for pure defensive exposure and favor the lower-volatility basket.

Key Decisions for Investors

• Long XLP / short IYK as a small relative-value pair for 1-3 months. Rationale: lower fee, higher liquidity, and cleaner staples purity should continue to attract marginal defensive flows. Risk/reward is modest, not a high-conviction trade; cover if IYK outperforms XLP by >2% on a monthly basis or if healthcare materially outperforms staples.
• Overweight WMT and COST on pullbacks over the next 6-12 months. They are the most direct beneficiaries of any continued defensive allocation into the larger staples basket. Do not chase at peak valuation; buy only on 5-8% drawdowns or after broad market volatility spikes.
• Avoid adding to STT on this thesis alone. The fee-revenue upside from the ETF flow story is too small to matter without evidence of sustained AUM migration. Reassess only if the SPDR staples franchise shows a durable net-flow inflection over a full quarter.
• Use KO and PM as relative underweights versus WMT/COST if you want to express the concentration effect. The article’s implied flow preference is for the cleaner, larger-cap defensive compounds rather than the broader defensive mix; the trade fails if consumer staples breadth broadens or tobacco re-rates on idiosyncratic catalysts.